Switch From Tenofovir to Raltegravir for Low Bone Mineral Density

NCT00939874 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

HIV
Osteopenia
Osteoporosis
HIV Infections

Interventions

DRUG: Raltegravir

Sponsor

St Vincent's Hospital, Sydney

Collaborators

[object Object]
[object Object]
[object Object]